Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perfusion index-guided versus mean arterial pressure-guided norepinephrine adjustment in septic shock
IRCT20250109064330N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of norepinephrine in septic shock (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Creatinine at 8 hours, Lactate at 8 hours and 7 more. Started Feb 2025; status: completed.
02
Drugs
norepinephrine
03
Conditions
septic shock
Beyond the preview
Go deeper on IRCT20250109064330N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250109064330N1.